secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001906324-24-000048
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q3 GAAP net loss $20M ($0.30 EPS); revenue $727M; reinstates 2024 guidance
--------------------------------------------------------------------------------

- Revenue $727M vs $744M YoY; Labs revenue grew 4% as reported (5% constant currency).
- GAAP net loss $20M ($0.30 diluted EPS) vs loss $13M ($0.19) prior year; GAAP operating margin 2%.
- Adjusted EBITDA margin 23.5%, up 80 bps; GAAP operating expenses down $13M to $242M.
- Company reinstated 2024 financial guidance after withdrawing prior outlook.
- Integration-related charges of $37M; new CTO and CHRO appointed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000048/0001906324-24-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000048/qdel-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001906324-24-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer